Atorvastatin Calcium
Product Images NDC 54868-6321

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 54868-6321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg Bottle Label (6319)

This appears to be the label of a medication called "ATORVASTATIN CALCIUM" in tablet form. The total quantity is 104 tablets. The text also shows an expiration date, but the rest of the information is not available due to poor quality .*

FDA Label Image

20mg Bottle Label (6320)

This is a product description for a pack of Atorvastatin Calcium tablets from a brand called Physicians Total Care. The pack contains 198 tablets and the price is shown as $41.00. There is no further information available.*

FDA Label Image

40mg Bottle Label (6321)

The text is not readable as it includes errors and incomplete information.*

FDA Label Image

80mg Bottle Label (6322)

FDA Label Image

Figure1 (Figatorva1)

FDA Label Image

Figure2 (Figatorva2)

FDA Label Image

Figure3 (Figatorva3)

FDA Label Image

Structure (Structureatorva)

FDA Label Image

Table 3 (Table3rev)

The table presents the effect of co-administered drugs on the pharmacokinetics of Atorvastatin. The table includes co-administered drugs and dosing regimens, Atorvastatin dose, and changes in AUC. Different drugs were used for up to 28 days, and the effects were evaluated. There were significant fold increases or decreases in AUC, and in some cases a change in dosing regimen was recommended. Grapefruit juice consumption may also increase the effects of Atorvastatin. The dose of the drugs in the study may not reflect their clinical use, so caution is advised.*

FDA Label Image

Table 4 (Table4)

The table shows the effect of atorvastatin on the pharmacokinetics of co-administered drugs. The drugs include antipyrine, digoxin, oral contraceptive, tipranavir, ritonavir, and fosamprenavir. The changes in AUC and Cya were also noted for each drug. Section 7 provides additional information on clinical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.